INS and fatty liver disease: The activation of the post-receptor signaling cascade induced by GLP-1 and GLP-1 receptor agonists and the consequent modulation of insulin signaling pathway would reduce storage of hepatocyte triglyceride and consequently improve hepatic steatosis [83].